Princess Kate is refocusing her energy in 2026 following her battle with cancer, according to a source. “Kate’s got so much ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

Multiple preservatives that are added to food products to lengthen their shelf life have significant associations with overall cancer development.

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

Photothermal therapy, as an emerging cancer treatment method, has attracted significant attention due to its advantages such ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

Summit Therapeutics Inc. ( SMMT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST ...